Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

March 2026

Beyond the Slide: Enabling Next-Generation AP TC/PC Workflow Efficiencies with Modern Digital Pathology Image Management Systems

2026-03-05T09:42:42+00:00

As digital pathology adoption accelerates across anatomic pathology, laboratories are rethinking how they scale operations, collaborate across sites, and maintain long-term sustainability. In our work with laboratories operating under Technical Component and Professional Component (TC/PC) models, one theme consistently emerges: traditional workflows are increasingly being stretched by the growing complexity, volume, and expectations of modern pathology [...]

Beyond the Slide: Enabling Next-Generation AP TC/PC Workflow Efficiencies with Modern Digital Pathology Image Management Systems2026-03-05T09:42:42+00:00

AI Cancer Tools Risk “Shortcut Learning” Rather Than Detecting True Biology

2026-10-06T08:47:06+00:00

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals. Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses, and cheaper testing. But new research from the University of Warwick, published [...]

AI Cancer Tools Risk “Shortcut Learning” Rather Than Detecting True Biology2026-10-06T08:47:06+00:00

New AI Model Predicts Breast Cancer Gene Expression from Standard Tissue Images

2026-03-02T10:08:16+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a new study, researchers at the Université de Moncton in Canada developed a hybrid deep learning architecture called EMGP-Net that can predict gene expression patterns directly from routine histopathological images, potentially eliminating the need for expensive spatial transcriptomics technologies. EMGP-Net combines two cutting-edge AI [...]

New AI Model Predicts Breast Cancer Gene Expression from Standard Tissue Images2026-03-02T10:08:16+00:00

February 2026

Mindpeak and IQVIA Laboratories Are Working Together to Advance Biomarker-driven Clinical Trials

2026-03-04T09:20:32+00:00

Mindpeak × IQVIA LaboratoriesAdvancing Biomarker-Driven Clinical Trials with AIPrecision oncology requires more than integration - it requires true collaboration. Mindpeak and IQVIA Laboratories are partnering to advance biomarker-driven clinical trials by combining global laboratory expertise with AI-powered tissue analysis.Together, we aim to enhance patient enrolment, enable more personalized patient insights, and support the development of CDx assessment [...]

Mindpeak and IQVIA Laboratories Are Working Together to Advance Biomarker-driven Clinical Trials2026-03-04T09:20:32+00:00

Ohio State Opens 26-story Hospital Building in Columbus

2026-03-05T09:10:56+00:00

The 1.9 million-square-foot University Hospital building adds nearly 400 beds to the university's Wexner Medical Center. Key Highlights The new facility has 24 operating rooms, including two hybrid neurovascular suites for complex stroke procedures. Rising 410 feet, the hospital is the 10th tallest building in Columbus, adding nearly 400 beds to the medical center. It [...]

Ohio State Opens 26-story Hospital Building in Columbus2026-03-05T09:10:56+00:00

ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

2026-03-04T14:01:02+00:00

ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization. [...]

ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners2026-03-04T14:01:02+00:00

Latin America Diagnostic Imaging Market to Reach US$ 492.1M by 2031 at 7.1% CAGR | Expands with MRI, CT and AI Adoption

2026-03-02T10:38:04+00:00

Latin America Diagnostic Imaging Market to reach US$492.1 Million by 2031, driven by AI integration, chronic disease rise, and healthcare modernization. The Latin America Diagnostic Imaging Market reached US$ 304.9 million in 2023 and is projected to reach US$ 492.1 million by 2031, growing at a CAGR of 7.1% during 2024–2031. The market is experiencing steady expansion [...]

Latin America Diagnostic Imaging Market to Reach US$ 492.1M by 2031 at 7.1% CAGR | Expands with MRI, CT and AI Adoption2026-03-02T10:38:04+00:00

Illumina Launches TruPath Genome, Setting a New Standard in Genomic Insight

2026-03-03T16:44:51+00:00

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow  Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease  Broad Clinical Labs is among first to adopt product, which was previously known as "constellation mapped read technology" Illumina, Inc. today announced the launch of TruPath™ Genome, setting a new [...]

Illumina Launches TruPath Genome, Setting a New Standard in Genomic Insight2026-03-03T16:44:51+00:00

Patient Perspectives on Trust in Artificial Intelligence – Powered Tools in Prostate Cancer Diagnostics

2026-02-27T09:40:14+00:00

The following abstract is drawn from a recently published paper in Sage Journals. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Simon Aleksander Berger1, Erna Håland1, and Marit Solbjør2 [...]

Patient Perspectives on Trust in Artificial Intelligence – Powered Tools in Prostate Cancer Diagnostics2026-02-27T09:40:14+00:00

Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics

2026-03-02T14:44:14+00:00

Epredia will add Mindpeak AI modules for pathology to its digital pathology portfolio, offering enhanced precision and speed in diagnostic image review Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation, and Mindpeak, a leading provider of artificial intelligence (AI) solutions for clinical and research pathology, today announced a [...]

Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics2026-03-02T14:44:14+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top